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The newly recognized bacterial second messenger 3,5-cyclic
diguanylic acid (cyclic diguanylate (c-di-GMP)) has been shown to
regulate a wide variety of bacterial behaviors and traits. Biosynthe-
sis and degradation of c-di-GMP have been attributed to the
GGDEF and EAL protein domains, respectively, based primarily on
genetic evidence. Whereas the GGDEF domain was demonstrated
to possess diguanylate cyclase activity in vitro, the EAL domain has
not been tested directly for c-di-GMP phosphodiesterase activity.
This study describes the analysis of c-di-GMP hydrolysis by an EAL
domain protein in a purified system. The Vibrio cholerae EAL
domain protein VieA has been shown to inversely regulate biofilm-
specific genes (vps) and virulence genes (ctxA), presumably by
decreasing the cellular pool of c-di-GMP. VieA was maximally
active at neutral pH, physiological ionic strength, and ambient tem-
peratures anddemonstrated c-di-GMPhydrolytic activitywith aKm
of 0.06M.VieAwas unable to hydrolyze cGMP.The putativemetal
coordination site of the EAL domain, Glu170, was demonstrated to
be necessary for VieA activity. Furthermore, the divalent cations
Mg2 and Mn2 were necessary for VieA activity; conversely, Ca2
and Zn2 were potent inhibitors of the VieA phosphodiesterase.
Calcium inhibition of the VieA EAL domain provides a potential
mechanism for regulation of c-di-GMP degradation.
The cyclic dinucleotide 3,5-cyclic diguanylic acid (c-di-GMP)2 has
been characterized as an important second messenger that affects a
range of physiological and behavioral traits in an assortment of bacterial
species. C-di-GMP was initially identified as an allosteric activator of
cellulose synthase in Gluconacetobacter xylinum (1). Similarly, c-di-
GMP has been implicated in regulation of cellulose biosynthesis and
biofilm formation in the Gram-negative enteric pathogen Salmonella
enterica serovar Typhimurium (2), as well as in survival of S. typhi-
murium in mice (3). Regulation of multicellular behaviors such as bio-
films is not limited to Gram-negative bacteria, since there is evidence
that c-di-GMP inhibits biofilm formation in Staphylococcus aureus as
well (4). In addition, c-di-GMP was shown to regulate the transition
between sessile andmotile phenotypes in S. typhimurium, the opportu-
nistic pathogen Pseudomonas aeruginosa, and commensal Escherichia
coli (5).
In the classical biotype of the facultative intestinal pathogen Vibrio
cholerae, not only does the c-di-GMP control biofilm formation (6), but
it also affects expression of virulence factors such as cholera toxin (CT)
(7). Specifically, increased intracellular concentrations of c-di-GMP
favor biofilm formation by activating expression of Vibrio exopolysac-
charide (vps) genes (6), which encode enzymes that produce the extra-
cellular matrix that provides the infrastructure for the characteristic
three-dimensional shape of biofilms. Decreased levels of c-di-GMP, on
the other hand, are associated with reduced vps expression and
increased production of CT (6, 7). The mechanisms involved in c-di-
GMP-mediated regulation of these phenotypes are entirely unknown.
The inverse regulation of environment-specific (biofilm) and infec-
tion-specific (virulence) genes is of particular interest because of the
shift in gene expression that is central to the pathogenic V. cholerae life
cycle. In endemic regions, V. cholerae is typically found in aquatic res-
ervoirs, and there is evidence that it forms biofilms on abiotic surfaces,
including the chitinous exoskeletons of zooplankton and phytoplankton
(8–10).V. cholerae undergoes a shift in gene expression upon entry into
the host; vps expression ceases (11), and expression of virulence genes is
induced (12–16). Whereas much research has been dedicated to study-
ing environmental forms, such as biofilms, and to elucidating mecha-
nisms of virulence gene regulation, little is understood about themolec-
ular mechanisms that control the shift from the environmental to
virulent state of V. cholerae. The intracellular concentration of c-di-
GMP and proteins that modulate c-di-GMP levels may be key determi-
nants in the transition from the environmental biofilm state to the vir-
ulent state of V. cholerae.
Biosynthesis and degradation of c-di-GMP have been predicted to
occur through the activities of diguanylate cyclases and phosphodies-
terases, respectively. These activities have been attributed to proteins
containing GGDEF and/or EAL domains (17, 18). The putative digua-
nylate cyclases contain a conserved domain with a Gly-Gly-Asp-Glu-
Phe motif (GGDEF, also known as domain of unknown function 1, or
DUF1) (18). The GGDEF domain has limited but significant homology
to eukaryotic adenylate cyclases (19). Synthesis of c-di-GMP by
GGDEF-containing enzymes involves the 3 to 5 linkage of two GTP
molecules into a cyclic molecule with the release of two pyrophosphate
groups (20). A number of GGDEF domain proteins have been demon-
strated to have diguanylate cyclase activity in vitro (21).
The putative c-di-GMP phosphodiesterases contain a domain
enriched in glutamic acid, alanine, and leucine (EAL; also the domain of
unknown function 2,DUF2). The functionswere initially assigned to the
GGDEF and EAL domains based on the occurrence of these sequences
in enzymes with the described activities. For example, inG. xylinum, in
which c-di-GMP metabolism was first characterized, six genes were
found that control the intracellular concentration of c-di-GMP, each
containing a GGDEF and an EAL domain (18, 22). The phosphodiester-
ase activity attributed to the EAL domain is based on limited homology
to eukaryotic nucleotide phosphodiesterases (reviewed in Ref. 23) and is
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predicted to result in the linearization of c-di-GMP to pGpG, a physio-
logically inactive dinucleotide; a second, presumably ubiquitous phos-
phodiesterase, PDE-B, would hydrolyze pGpG to two GMP molecules.
Genes encoding proteins with GGDEF and/or EAL domains are
abundant in bacterial genomes, usually in combination with other reg-
ulatory or sensory domains. In V. cholerae, 22 open reading frames
encode proteins with homology to the EAL module, and 40 encode
GGDEF domain proteins. There is considerable overlap of these pro-
teins, as 10 possess both domains. One particular EAL domain protein
of interest, VieA, is a putative response regulator with a conserved
N-terminal phosphoreceiver domain, an internal EAL domain, and a
C-terminal helix-turn-helix DNA binding domain. Encoded in the
vieSAB three-component signal transduction system operon, the vieA
locus has been demonstrated to be required for virulence of V. cholerae
in the infant mouse (24). A vieA mutant demonstrates decreased CT
production and 10-fold attenuated virulence (7, 24).Moreover, deletion
of vieA results in increased intracellular c-di-GMP, vps expression, and
biofilm formation (6). Conversely, overexpression of VieA decreases
c-di-GMP levels and vps expression (6). Mutation of the phosphore-
ceiver or DNA-binding domains of VieA does not affect these pheno-
types, whereasmutation of the central EAL domain does (6, 24). Expres-
sion of VieA and subsequent c-di-GMP activity during infection may
thus be a critical signal, mediated by the modulation of c-di-GMP con-
centrations, for V. cholerae to down-regulate environment-specific
genes and increase production of virulence factors.
There is a large body of indirect evidence that proteins containing the
EAL domain possess c-di-GMP phosphodiesterase activity. Recently,
the EAL domain was demonstrated to possess phosphodiesterase activ-
ity on an unnatural substrate, but the specificity of the EAL domain for
c-di-GMPwas not addressed (25). In the presentwork, we show that the
EAL domain protein VieA acts as a c-di-GMP phosphodiesterase in a
purified system. In addition, we have characterized the enzymatic prop-
erties of VieA in terms of optimal reaction conditions, ion requirement,
ion inhibition, and kinetics.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions—Strains used in this study are listed
in TABLE ONE. V. cholerae were grown in LB broth containing 100
g/ml streptomycin at 37 °C with aeration. E. coliwere incubated in LB
containing 50g/ml ampicillin or 10g/ml chloramphenicol, as appro-
priate, at 37 °Cwith aeration, except during induction of protein expres-
sion (see details below).
Cloning of EAL Domain Proteins—Full-length vieA and vieAE170A
were cloned into expression vector pMMB67EH. Briefly, wild type vieA
and the E170A point mutant were amplified from AC61 genomic DNA
by PCR using primers vieAF2 (5-CGAGCTCTTTAGGATACATTT-
TTATGAAAATAATGATAGTAGAAG-3) and CHVAR1 (5-AAC-
TGCAGCTAATGATGATGATGATGATGTTTTAATGTTACAAA-
ACGCAC-3). Primer vieAF2 introduced a SacI restriction site
(underlined), a ribosomal binding site (italicized), and a start codon
(boldface type). Each reverse primer introduced a PstI site (underlined),
a His6 tag (italicized), and a stop codon (boldface). The PCR fragments
were digested with SacI and PstI, ligated into pMMB67EH, and trans-
formed into E. coli DH5 by electroporation. The correct clones were
confirmed by digestion and sequencing.
Purification of EAL Domain Proteins—Expression of His6-tagged
EALproteinswas induced in exponential growth phase bacteriawith 0.5
mM isopropyl 1-thio--D-galactopyranoside at 30 °Cwith aeration. Bac-
teria were collected by centrifugation and resuspended in His6 buffer
consisting of 10 mM Tris, pH 8, 300 mM NaCl, 50 mM NaH2PO4, 10%
glycerol, 1 mM phenylmethylsulfonyl fluoride, and 2 mM imidazole. All
subsequent steps were carried out at 4 °C. The suspensions were lysed
by French press at 16,000 p.s.i. and then briefly sonicated to break up
genomic DNA. The lysates were fractionated by centrifugation at
10,000 g for 30min. The soluble fraction (supernatant) was incubated
withNi2-nitrilotriacetic acid-agarose resin (Qiagen) for 1 hwith gentle
rocking. Subsequently, the samples were applied to a 5-ml polypro-
pylene column (Qiagen), and the resin was allowed to settle. After elu-
tion of the His6 buffer, the column was washed twice with wash buffer
(His6 buffer, 40 mM imidazole). The His6-tagged proteins were eluted
from the column with elution buffer (His6 buffer, 250 mM imidazole)
and then dialyzed overnight in Slide-A-Lyzer 10,000 molecular weight
cut-off dialysis cassettes (Pierce) against 75 mM Tris, pH 8, 250 mM
NaCl, 25 mM KCl, 10 mM MgCl2, 30% glycerol. The lysates, column
washes, and elutions were analyzed by SDS-PAGE and Coomassie Bril-
liant Blue staining to assess protein purity. The concentrations of the
purified protein samples were determined using the modified Lowry
protein assay kit (Pierce). Dialyzed proteins were stored at 20 °C.
Synthesis of c-di-GMP Substrate—C-di-GMP substrate for the phos-
phodiesterase assays was synthesized enzymatically using the VCA0956
protein, which contains a GGDEF diguanylate cyclase domain.




Primer A0956F2 introduced an XbaI restriction site (underlined), a
ribosomal binding site (boldface type), and an N-terminal His6 tag (ital-
icized). Primer A0956R introduced an SphI site (underlined) after the
stop codon. The PCR fragment was digested and ligated into the arabi-
nose-inducible expression vector pBAD33 and transformed into E. coli
DH5. Clones were confirmed by digestion and sequencing. Protein
expression was induced in exponential phase cells using 0.2% L-arabi-
nose. His6-VCA0956 was purified by Ni2-nitrilotriacetic acid affinity
chromatography using methods similar to those described for purifica-
tion of the EAL domain proteins, except the His6 binding buffer con-
tained 35 mM imidazole, and the His6 wash buffer contained 50 mM
imidazole.
Purified His6-VCA0956 (60 ng/l) was incubated 4 h to overnight at
23 °Cwith 3l of [-32P]GTP (3000 Ci/mmol, 3.3M; PerkinElmer Life
Sciences) in buffer containing 75 mM Tris, pH 8, 250 mM NaCl, 25 mM
KCl, and 10mMMgCl2.When higher concentrations of c-di-GMPwere
desired, unlabeled GTP was included at 0.01 or 0.1 mM final concentra-
TABLE ONE
Strains used in this study
Strain Description Reference/Source
AC61 Classical V. choleraeO395 lacZ::res-tet-res. Ref. 33
AC575 DH5 pMMB67EH Ref. 38
AC1596 V. choleraeO395 vieAE170A Ref. 6
AC1758 E. coli DH5 pBAD33::His6-VCA0956 This work
AC1817 E. coli DH5 pMMB67EH::vieA-His6 This work
AC1835 E. coli DH5 pMMB67EH::vieAE170A-His6 This work
VieA c-di-GMP Phosphodiesterase
SEPTEMBER 30, 2005 • VOLUME 280 • NUMBER 39 JOURNAL OF BIOLOGICAL CHEMISTRY 33325
tions. The reactions were treated with calf intestinal phosphatase (New
England Biolabs) for 30 min to hydrolyze noncyclized phosphate
groups. The c-di-GMP product was separated from proteins by centrif-
ugation through an Ultrafree-MC 5000 molecular weight cut-off col-
umn (Centricon) for 45 min at 5000  g. Reaction products were sepa-
rated by thin layer chromatography using polyethyleneimine (PEI)-
cellulose plates and 1.5 MKH2PO4, pH 3.65, buffer (1) and then analyzed
by phosphorimagery and volume analysis using ImageQuant 1.2. The
final concentration and yield of c-di-GMPwere calculated based on the
percentage incorporation of radiolabeled GTP into radiolabeled c-di-
GMP. Products were stored at 20 °C.
Phosphodiesterase Assays—The standard phosphodiesterase assay
involved incubating purified protein with 11 nM [32P]c-di-GMP (no
unlabeled c-di-GMP) for 30 min to 1 h at room temperature in 75 mM
Tris, pH 8, 250 mM NaCl, 25 mM KCl, and 10 mM MgCl2. A no enzyme
negative control and a snake venom phosphodiesterase (SVPD; Amer-
sham Biosciences, product number E20240Y) positive control were
included in all assays. The reactions were stopped by spotting 0.5 l of
the reaction on PEI-cellulose and allowing it to air-dry. Nucleotides
were separated by TLC in 1.5 M KH2PO4, pH 3.65, and visualized by
phosphorimagery.
The following experiments were done to determine the optimum
parameters for phosphodiesterase activity (1). To determine the opti-
mal reaction temperature, a master mix of the above reaction was ali-
quoted (30l) and incubated in heat blocks at 4, 16, 23, 30, 37, 45, 52, 65,
or 80 °C (2). For optimization of reaction pH, the pH of the standard
buffer described above was adjusted with HCl or NaOH to pH 3.5–12
(3). The optimum Mg2 concentration for VieA activity was deter-
mined using 75mMTris, pH8, and 150mMKCl;MgCl2was added to the
reaction at 0–100 mM final concentrations (4). The optimal ionic
strength for the reaction was determined by measuring activity in 75
mMTris, pH 8, 25mMMgCl2, and 0–500mMKCl. For each experiment,
0.5 l were analyzed by TLC after 45 min. Experiments addressing the
inhibitory effects of divalent cations were performed at 23 °C using 75
mM Tris, pH 8, 25 mM KCl, 25 mM MgCl2, and 0.33 M c-di-GMP and
analyzed as described. For all experiments, the percentage hydrolysis of
c-di-GMP was determined. All assays were performed in triplicate.
The requirement of VieA for divalent cations was evaluated by first
chelating divalent cations from the protein and substrate preparations.
Briefly, Chelex-100 was added to 100-l aliquots of VieA or c-di-GMP
at 10 mg of Chelex-100 per ml and incubated for 10 min at room
temperature. The protein or substrate was then transferred to fresh
Chelex-100; this was repeated for a total of five treatments. The final
incubation was allowed to proceed for 1.5 h at room temperature. Che-
lated samples were stored at 20 °C. The protein samples were con-
firmed to lack phosphodiesterase activity by incubating with [32P]c-di-
GMP in reaction buffer lacking MgCl2. Divalent cations from MgCl2,
CaCl2, MnCl2, and ZnCl2 were reconstituted into 75 mM Tris, pH 8,
reaction buffer at 50mM final concentrations. VieAwas incubated in the
buffer for 1 min prior to the addition of substrate. Phosphodiesterase
activity was assayed in reactions containing each divalent cation alone
or in combination (equimolar concentrations) with Mg2 for 1 h at
room temperature, analyzed by TLC, and quantified as percentage
hydrolysis of c-di-GMP.
VieA kinetics experiments were done using the determined opti-
mized conditions of 75 mM Tris, pH 8, 25 mM KCl, 25 mM MgCl2 at
23 °C. Measurements were done with independently purified protein
preparations. Because substrate concentrations were limiting, VieAwas
diluted to yield linear initial reaction rates. For the data shown, 0.013g
of protein was used. C-di-GMP was included in the reactions at a range
of concentrations between 11 nM and 0.91 M. At 30-s intervals, ali-
quots of the phosphodiesterase reactions were spotted on PEI-cellulose
plates for TLC and densitometry analysis. Mol of c-di-GMP hydrolyzed
at each time point were calculated based on the percentage of total
c-di-GMP hydrolyzed. Initial velocities of the reactions were deter-
mined by calculating the slope of the linear part of the reaction. Km and
Vmax values were calculated using the Michaelis-Menten equation and
Lineweaver-Burk methods.
To address the substrate specificity of VieA, phosphodiesterase
assays were performed as described for c-di-GMP, except 1 g of VieA
and 13 nM [3H]cGMP (MP Biomedicals) were used. The reactions were
incubated at 23 °C for 30 min to 16 h, and then the products were
analyzed by TLC using PEI-cellulose plates and development in a sol-
vent consisting of 5:2 methanol, 1 M ammonium acetate (26). The dried
plates were cut to separate the lanes of the individual samples and then
divided into 40 sections 0f 0.5 cm each. Each section was placed in
Ecoscint-A scintillation fluid (National Diagnostics), and counts were
measured using a Beckman LS 5000TD counter. The presence of
[3H]cGMP and [3H]GMPwas determined by comparing the location of
sections with radioactivity relative to the published RF values of these
molecules (26). A no enzyme negative control and SVPD-positive con-
trol were included in these experiments.
Purification of pGpG—c-di-GMP, synthesized and purified as
described above, was used as substrate in a reaction with VieA, and
nucleotides were separated by TLC. Spots corresponding to pGpG in
the PEI-cellulose matrix were removed from the flexible backing of the
TLC plate. pGpG was extracted from the material twice by resuspend-
ing in 0.5 M (NH4)2CO3 (1) and vortexing vigorously to solubilize the
nucleotides. After a 15-min incubation at 23 °C, the supernatant con-
taining pGpG was collected and centrifuged to remove any remaining
PEI-cellulose debris.
VieA-His6, VieAE170A-His6, and mock-purified protein from the
vector control were tested for the ability to degrade pGpG to GMP in
phosphodiesterase assays set up as described above, except pGpG was
substituted for c-di-GMP. Reaction products were analyzed by TLC.
RESULTS
Detection of c-di-GMP Phosphodiesterase Activity by VieA—His6-
tagged VieA and VieAE170A, which contains a point mutation in the
putative magnesium coordination site, were expressed and purified in
E. coli DH5 to greater than 95% purity as determined by SDS-PAGE
and Coomassie staining (Fig. 1A). These preparations, as well as that
from the vector control processed in parallel, were tested for the ability
to hydrolyze 32P-labeled c-di-GMP. Substrate and products were
detected using TLC and phosphorimagery (1). All RF values for nucle-
otide species detected in these assays agreed with those identified pre-
viously (1). The SVPD control rapidly hydrolyzed c-di-GMP (RF  0.27)
to GMP (RF  0.61). It was apparent that the VieA preparation was
capable of degrading c-di-GMP due to the disappearance of the spot at
RF  0.27 (Fig. 1B). Interestingly, the hydrolytic products present in the
VieA reaction included pGpG (RF  0.55) as well as GMP (RF  0.61).
The appearance of GMP as a product of VieA activity is addressed
below. Furthermore, whereas SVPDwas able to hydrolyze cGMP, VieA
was not, indicating that VieA phosphodiesterase activity was specific to
c-diGMP (data not shown).
The highly conserved Glu residue of the EAL motif, Glu170, was pre-
dicted to be part of the coordination site for a divalent cation, specifi-
cally Mg2 (23). Previous studies by our laboratory showed that muta-
tion of conserved Glu170 to Ala abolished the ability of VieA to repress
vps expression; the same effect was seen with deletion of vieA and had
the downstream effect of increasing biofilm formation (6). This pheno-
type was attributed to an increase in intracellular c-di-GMP due to
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mutation of the putative EAL PDE. Our studies confirmed that the
VieAE170A protein is unable to hydrolyze c-di-GMP (Fig. 1B).
Activation and Inhibition of VieA Activity by Divalent Cations—Ross
et al. characterized c-di-GMP phosphodiesterase activity in cellulose
synthase-containing membranes of G. xylinum (1). This activity was
stimulated by the addition of 10 mM Mg2 to the membrane extracts
and strongly inhibited by the presence of 2 mM Ca2. Based on these
data, the effect of these divalent cations, as well as Mn2 and Zn2, on
VieA phosphodiesterase activity was investigated.
Aliquots of VieA and [32P]c-di-GMP substrate were treated with
Chelex-100 to remove divalent cations present in the storage buffers
until no phosphodiesterase activity was evident (Fig. 2, lane 4). The
reactions were reconstituted with Mg2, Mn2, Zn2, or Ca2 individ-
ually or in combination. Mg2 was able to restore phosphodiesterase
activity toVieA, although not to the level present in non-Chelex-treated
protein (Fig. 2, lane 3 versus lane 5). This is possibly due to degradation
of the protein duringChelex-100 treatment at room temperature. Alter-
natively, chelation ofMg2may have yielded a fraction of VieA inwhich
proper folding could not be restored upon reintroduction of Mg2.
Mn2 could restore phosphodiesterase activity to 55% of that seen
with Mg2. Neither Zn2 nor Ca2 permitted detectable hydrolysis of
c-di-GMP in these assays. Interestingly, the addition of these cations in
equimolar amounts as Mg2 abolished VieA activity, suggesting an
inhibitory role for Zn2 and Ca2. Furthermore, providing equimolar
amounts of Mn2 and Mg2 to the reaction gave activity similar to
providing Mn2 alone (57% activity). These results suggest that Mn2,
Ca2, and Zn2 may have higher affinity thanMg2 for the VieAmetal
coordination site.
To further investigate VieA inhibition by Ca2 and Mn2, the con-
centration of these cations that reduced VieA phosphodiesterase activ-
ity to 50% was determined. VieA activity was extremely sensitive to
Ca2; in reactions containing 0.43 mMVieA and 25 mMMgCl2, 100 M
CaCl2 was able to reduce activity to one-half Vmax. In contrast, 50–75
mM MnCl2 was required to reduce VieA activity to one-half Vmax, and
even 500 mMMnCl2 was unable to inhibit activity completely, decreas-
ing the reaction rate to 37% of Vmax. The Mg2 concentration neces-
sary for optimal VieA activity was determined by performing the phos-
phodiesterase assays using a range of MgCl2 from 0 to 100 mM. VieA
phosphodiesterase activity increasedwith increasingMg2 up to 25mM
MgCl2 (data not shown). Further increases in Mg2 had no positive or
negative effects on activity.
Optimization of VieA Reaction Conditions—The parameters for the
VieA phosphodiesterase reaction were optimized for temperature, pH,
and ionic strength (Fig. 3, A–C). For determination of optimal temper-
ature, VieA activity was analyzed at temperatures ranging from 4 to
80 °C. VieA activity was significantly impaired at 52 °C and above, and
no phosphodiesterase activity was apparent at 65 °C or above (not
shown). Reaction rates were best and comparable at 23 and 30 °C after a
45-min incubation, suggesting that VieA phosphodiesterase is most
FIGURE 1. Protein expression and detection of enzyme activity. His6-tagged VieA and
VieAE170A were purified using Ni2-nitrilotriacetic acid column chromatography and
tested for the ability to hydrolyze enzymatically synthesized, radiolabeled c-di-GMP sub-
strate. A, purity of VieA and VieAE170A protein preparations as determined by SDS-PAGE
analysis and Coomassie staining. His6-tagged VieA and VieAE170A are 66 kDa. B, VieA
(1 g), VieAE170A (5 g), and controls were incubated with [32P]c-di-GMP, and then
reaction products were analyzed by TLC. VieA, but not VieAE170A or the vector control,
demonstrated c-di-GMP phosphodiesterase activity. Lane 1, no enzyme control; lane 2,
SVPD; lane 3, VieA; lane 4, VieAE170A; lane 5, vector control. Products of the reactions are
labeled on the right. Cyclic diguanylate (c-di-GMP) migrated at RF  0.27; pGpG migrated
at RF  0.55; and GMP migrated at RF  0.61.
FIGURE 2. Divalent cation requirement of VieA.
Divalent cations were removed from the VieA
preparation by treatment with Chelex-100 until no
activity was detected (lane A4). To determine
which cations could support VieA phosphodies-
terase activity, the protein was reconstituted with
Mg2, Mn2, Zn2, and Ca2 individually or in
combination with Mg2, each at a concentration
of 50 mM, and then tested for the ability to hydro-
lyze c-di-GMP. Mg2 and, to a lesser extent, Mn2
could restore VieA phosphodiesterase activity
(lanes 5 and 6). Ca2 and Zn2 not only failed to
reinstate activity (lanes 7 and 8) but also abolished
c-di-GMP hydrolysis by VieA in the presence of
equimolar concentrations of Mg2 (lanes 10
and 11).
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active at ambient temperatures; subsequently, all reactions were incu-
bated at 23 °C.
Rates of c-di-GMPhydrolysis weremeasured at awide range of buffer
pH (3.5–12). Activity peaked at neutral pH; there were no significant
differences in reaction rates at pH between 5 and 9, indicating that VieA
is not extremely sensitive to pH. Because pH 8 consistently gave some-
what higher reaction rates than the others tested, pH 8 was used in
subsequent assays.
The ionic strength of theVieA phosphodiesterase reaction buffer was
also optimized. To the VieA buffer containing 75mMTris, pH 8, and 25
mMMgCl2, 0–500 mM KCl was added. C-di-GMP hydrolysis was com-
parable for 0–50 mM KCl and decreased with further increases in KCl,
suggesting inhibition of activity at high ionic strength, possibly due to
masking of charges and reduced electrostatic interaction betweenMg2
and the metal coordination site of VieA. Similar results were apparent
when NaCl was used to adjust ionic strength (data not shown). The use
of 25 mMKCl in the reaction consistently gave the highest VieA activity
and was used in subsequent experiments. The ionic strength of this
reaction is190mM, which falls in the physiologically relevant range of
150–200 mM. Examination of activity at very low ionic strength was
limited by the minimum amount of MgCl2 required for maximal c-di-
GMP hydrolytic activity.
Kinetics of VieA c-di-GMP Phosphodiesterase Activity—The optimal
reaction conditions determined above were used to analyze the kinetics
of VieA c-di-GMP hydrolytic activity. VieA phosphodiesterase activity
demonstrated standardMichaelis-Menten kinetics.Km andVmax values
were determined for VieA using two independently expressed and puri-
fied preparations of enzyme. The Km and Vmax calculated for each pro-
tein preparation were very similar. VieA demonstrated aKm of 0.06 M,
suggesting high affinity of VieA for c-di-GMP. Vmax was determined to
be 20.5 mol min1 mg1 protein.
Phosphodiesterase B Activity of VieA—It has been suggested that a
phosphodiesterase different from the EAL domain phosphodiesterase,
PDE-B, hydrolyzes pGpG to GMP (27). Our experiments with VieA
showed thatGMP appeared onlywhen higher concentrations of protein
were used (data not shown). This introduced the possibility that a sec-
ond phosphodiesterase was present in the VieA preparations. To
address whether the appearance of GMP was due to a PDE-B contam-
inant, VieA, VieAE170A, and vector controls were used in phosphodi-
esterase assays using purified pGpG as substrate. Whereas SVPD was
able to hydrolyze pGpG to GMP, neither VieA, VieAE170A, nor the
vector control reactions showed GMP product after a 2-h incubation
(Fig. 4). Even after 24 h, only a trace amount of GMP (3%) was appar-
ent in these reactions, compared with 1% for the c-di-GMP only con-
trol. Thus, if small quantities of a PDE-B are present, they are not
responsible for the substantial amount of GMP that appears after a
45-min incubation of VieAwith c-di-GMP. Because VieAwas unable to
hydrolyze pGpG to GMP when given pGpG as a substrate, it is possible
that VieA can hydrolyze pGpG to GMP at a low rate when bound as an
FIGURE 3. Optimization of VieA reaction conditions. A, the VieA phosphodiesterase
reaction was performed at a range of temperatures from 4 to 80 °C. The highest rate of
c-di-GMP hydrolysis was achieved at 23 and 30 °C. No activity was detectable at temper-
atures above 52 °C, but some c-di-GMP hydrolysis occurred at low temperatures. B, the
pH of the phosphodiesterase reaction was adjusted to 3.5–12 prior to the addition of
enzyme and substrate. VieA activity was comparable at pH between 5 and 9 and was
inhibited at extreme basic or acidic pH. C, the ionic strength was adjusted upwards from
the standard reaction buffer by the addition of 0 –500 mM KCl. VieA activity was essen-
tially the same with up to 50 mM added KCl; the total ionic strength of the reaction buffer
is physiologically relevant. Further increases in ionic strength inhibited VieA phosphodi-
esterase activity, but only slightly. A–C, the data shown represent the mean percentage
of substrate that was hydrolyzed in three independent experiments.
FIGURE 4. Hydrolysis of pGpG. The potential presence of contaminants with PDE-B
activity in the protein preparations was addressed by incubating VieA, VieAE170, and
vector control samples with radiolabeled pGpG as the substrate. Whereas SVPD could
hydrolyze pGpG (RF  0.55) to GMP (RF  0.61), no other reaction showed GMP product
after 24 h, verifying that no PDE-B contaminant was present.
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intermediate during c-di-GMP hydrolysis but cannot bind pGpG when
introduced exogenously.
DISCUSSION
There has been increasing interest in the novel second messenger
c-di-GMP and in its effect on bacterial gene regulation. A role for c-di-
GMP has been demonstrated in regulation of exopolysaccharide bio-
synthesis, motility, and virulence in a variety of bacteria, both Gram-
negative and Gram-positive (1–5, 25). With the exception of cellulose
biosynthesis in G. xylinum and A. tumefaciens, in which c-di-GMP
functions as an allosteric activator of cellulose synthase (1, 17), the
mechanism by which c-di-GMP modulates these phenotypes is
unknown. However, there has been significant progress in understand-
ing themetabolism of c-di-GMP. Genetic studies of genes encoding the
GGDEF domain, which possesses weak homology to eukaryotic adeny-
late cyclases, provided evidence that the GGDEF domain functions as a
c-di-GMP cyclase (17). Recently, GGDEF proteins from bacteria repre-
senting the major phylogenetic branches were purified and demon-
strated to have diguanylate cyclase activity in vitro (21).
Similar to the GGDEF domain, the assignment of c-di-GMP hydro-
lytic activity was initially ascribed to the EAL domain based on genetic
evidence (5, 6, 18). For example, mutation of the EAL-encoding gene
vieA resulted in increased levels of c-di-GMP in nucleotide extracts (6).
This work demonstrates c-di-GMP hydrolytic activity by the EAL-con-
taining protein VieA. VieA was selected as the EAL protein of interest
because of its role in regulation of vps expression and biofilm formation,
and in CT expression and virulence of V. cholerae, a facultative intesti-
nal pathogen. Furthermore, previous work investigating EAL domain
function could not specifically attribute c-diGMP phosphodiesterase
activity to the EAL domain, because the GGDEF domain was present in
these proteins as well or because the protein contained both domains
but showed primarily diguanylate cyclase activity (18). VieA lacks a
GGDEF domain, which allows unambiguous assignment of c-diGMP
phosphodiesterase activity to the EAL domain.
Using enzymatically synthesized c-di-GMP substrate, VieAwas dem-
onstrated to possess c-di-GMP hydrolytic activity. Protein preparations
of vector alone, processed in parallel, demonstrated no activity. The
conservedGlu residue (Glu170) in the EAL domain, whichwas predicted
to be a divalent ion coordination site and probably required for EAL
activity (23), was confirmed to be necessary for VieA activity, since an
E170A mutation abolished c-di-GMP phosphodiesterase activity of the
protein. The measured Km of VieA for c-di-GMP was calculated to be
0.06M.ThisKm is considerably lower than that of other bacterial cyclic
nucleotide phosphodiesterases. For example, CpdA, a cAMP phospho-
diesterase of E. coli, has a Km of 0.5 mM cAMP (28). A Vibrio fischeri
zinc-containing cyclic nucleotide phosphodiesterase showed a lower
Km of 73 M cAMP (29). Themeasured Km for VieA is also 4-fold lower
than theKmmeasured for phosphodiesterase-containingmembranes of
G. xylinum, 0.25 M (27), suggesting high affinity of VieA for this
substrate.
The VieA EAL domain protein appears to be specific for the c-di-
GMP substrate. Whereas SVPD is a promiscuous phosphodiesterase
that can hydrolyze among others c-di-GMP, pGpG, cGMP, and cAMP,
c-di-GMP was the only substrate tested that could be hydrolyzed by
VieA. Previous studies by Ross et al. (27) addressed the ability of phos-
phodiesterase-containing membranes to hydrolyze cGMP and c-di-
GMP analogues, including c-di-IMP, c-di-AMP, c-di-CMP, and diaste-
reoisomers of c-di-GMP, so the latter were not considered in this work.
Ross et al. (27) predicted that EALphosphodiesterases function solely
in the first step of c-di-GMP hydrolysis to yield pGpG and that a second
enzyme, PDE-B, degrades pGpG to GMP. Analysis of the VieA reaction
products by TLC showed that not only was the linear pGpG product
formed, but GMP was produced as well. Because GMP was detectable
only in reactions containing 10–100-fold higher concentration of pro-
tein than was used in the kinetics studies, the possibility arose that a
PDE-B was present as a contaminant in the protein preparation. How-
ever, direct testing of VieA, VieAE170A, and the vector control for the
ability to hydrolyze pGpG as a substrate failed to detect a PDE-B. This
was not due to a defect in the purification of pGpG, since the SVPD-
positive control was able to hydrolyze pGpG to GMP, implying that
PDE-B activity detected in these assays can be ascribed toVieA. Because
the rate of GMP formation was orders of magnitude slower than that of
pGpG, the PDE-B activity of VieA is probably not physiologically
significant.
An intriguing result of this assay was that GMP product was not
formed in the VieA reaction when pGpG was provided exogenously as
the substrate. It is possible that VieA does not bind exogenous pGpG
efficiently and thatGMP is only producedwhen pGpG is already bound,
immediately following the initial hydrolysis of c-di-GMP. Preliminary
binding studies investigating the ability of VieA to bind c-di-GMP and
pGpG support the hypothesis that VieA has very low affinity for pGpG
relative to c-di-GMP (data not shown). Alternatively, because VieA also
is predicted to be a response regulator, which often bindDNA as dimers
to control transcription (30–32), it is possible that dimerization of VieA
also affects its enzyme activity, specifically inmediating hydrolysis of the
pGpG intermediate product. It is unlikely that VieA dimerization is
required for the initial hydrolytic cleavage of c-di-GMP, since the con-
served response regulator domains can be deleted from VieA without
affecting its regulatory activity on vps expression (6). Determination of
the crystal structure of VieA may elucidate the potential overlap
between the presumed regulatory function of VieA and its enzymatic
activity.
As a potential dual function protein, VieA phosphodiesterase and
response regulator activities may be affected by phosphorylation. Phos-
phorylation of response regulators of two- and three-component regu-
latory systems typically increases affinity of the protein for its target
promoter DNA and thus increases expression of that gene. Phosphoryl-
ation of VieA may positively or negatively affect its enzyme activity as
well. Preliminary studies with VieA phosphorylated in vitro with acetyl
phosphate suggest that there is no significant change in the rate of VieA
hydrolysis of c-di-GMP (data not shown). In addition, deletion of the
VieA phosphoreceiver domain, as stated above, or mutation of the con-
served aspartic acid residue that is predicted to be the site of phospho-
rylation of VieA had no effect on the ability of the VieA EAL domain to
repress expression of vps genes (6). Thus, we do not expect phosphoryl-
ation to affect the phosphodiesterase activity of VieA.
VieA was determined to have optimal activity at neutral pH, physio-
logical ionic strength, and ambient temperatures. The in vitro optimum
conditions with respect to pH and ionic strength coincided with those
expected to be experienced by VieA in the bacterial cytoplasm. The
temperature optimum is consistent with the facultative pathogen
nature of V. cholerae, which includes growth in the human small intes-
tine at 37 °C and growth in aqueous reservoirs in temperate zones
around the world. V. cholerae encodes 21 additional EAL domain pro-
teins and 41GGDEF proteins (10 of these have both domains) (23), each
of which could potentially affect the intracellular pools of c-diGMP.
Interestingly, like VieA, other GGDEF and EAL proteins often contain
sensory/regulatory modules that could participate in signal transduc-
tion. This introduces the likelihood that subsets of GGDEF and/or EAL
domain proteins are expressed under specific conditions. The vieSAB
locus, for example, is expressed at low levels during growth in LB broth
in vitro but is induced during infection of the mouse as well as during
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growth in minimal medium supplemented with the amino acids Asn,
Arg, Glu, and Ser (6, 33, 34). Other GGDEF and EAL proteins may
dominate under other, as yet undefined conditions.
Strong inhibition of VieA c-diGMP phosphodiesterase activity by
Ca2 was observed in these studies, supporting earlier findings using
phosphodiesterase-containing membrane preparations (1). In fact,
Ca2 and Zn2 inhibited activity even when VieA was preincubated
with MgCl2, so VieA presumably was saturated with Mg2, suggesting
that Ca2 is capable of displacing Mg2 from the metal coordination
site. These findingsmay be important for understanding the function of
proteins in which both GGDEF diguanylate cyclases and EAL phospho-
diesterase domains are present. In such proteinswith domains of oppos-
ing functions, regulation of the individual domains is likely to be critical,
and Ca2 may provide a means by which c-di-GMP hydrolysis can be
inhibited. In this model, the presence of Ca2 would repress c-di-GMP
hydrolysis, allowing c-di-GMP to accumulate through the activity of
GGDEF activity. Regulation of GGDEF activity by divalent cations has
not been described.
Ca2 inhibition of c-di-GMP degradation by EAL domain proteins
has particularly interesting implications with regard to V. cholerae bio-
film formation. Formation of most V. cholerae biofilms is dependent on
the production of exopolysaccharide (VPS) (35). However, VPS-inde-
pendent biofilms that form in seawater have been described (36, 37).
These biofilms have an altered architecture and cell-cell interaction that
appear to be mediated by contacts between the lipopolysaccharide
O-antigen of adjacent bacteria and are dependent on the presence of
Ca2 in the growth medium. Previous studies by our laboratory have
demonstrated thatmutation of an EAL can cause increased intracellular
c-di-GMP and increased VPS-dependent biofilm formation. Similarly,
inhibition of EAL activity by Ca2 may positively regulate VPS-inde-
pendent biofilm development as well. Because biofilm formation is
thought to promote survival of V. cholerae in the environment, and
because biofilm-associated V. cholerae are predicted to be more infec-
tious due to protection froma variety of antimicrobial agents, regulation
of c-di-GMP metabolism by Ca2 may be important to V. cholerae
fitness in certain environments.
The bacterial second messenger c-di-GMP is being implicated in a
wide variety of bacterial phenotypes, especially multicellular behaviors
such as biofilms. In addition, there is evidence in V. cholerae and
S. typhimurium that c-di-GMP can regulate virulence phenotypes as
well. C-di-GMP may be a more global regulator of bacterial gene and
protein regulation than is realized, so it is critical that we understand the
metabolism of this compound. These experiments provide the first
direct evidence that an EAL domain protein, VieA, possesses c-di-GMP
hydrolytic activity in a purified system. Moreover, Ca2 inhibition may
provide a means of regulating EAL-mediated degradation of c-di-GMP.
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